{"filing":{"accession_number":"0001326110-26-000064","cik":"0001326110","ticker":"IBRX","company_name":"ImmunityBio, Inc.","form":"8-K","filing_date":"2026-06-10","report_date":null,"primary_document":"ibrx-20260609.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000064/ibrx-20260609.htm"},"events":[{"id":5712,"run_id":5005,"accession_number":"0001326110-26-000064","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure presents the results of ImmunityBio's 2026 Annual Meeting of Stockholders held on June 9, 2026, including voting outcomes for the election of nine directors and ratification of Deloitte \u0026 Touche LLP as independent auditor. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders. These outcomes are material to investors as they confirm the composition of the board and auditor selection.","company_name":"ImmunityBio, Inc.","ticker":"IBRX","filing_date":"2026-06-10","form":"8-K","submitted_at":null,"items":[{"id":5999,"accession_number":"0001326110-26-000064","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the results of ImmunityBio's 2026 Annual Meeting of Stockholders held on June 9, 2026, including voting outcomes for the election of nine directors and ratification of Deloitte \u0026 Touche LLP as independent auditor. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders. These outcomes are material to investors as they confirm the composition of the board and auditor selection.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T21:25:05.804840+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5999,"accession_number":"0001326110-26-000064","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the results of ImmunityBio's 2026 Annual Meeting of Stockholders held on June 9, 2026, including voting outcomes for the election of nine directors and ratification of Deloitte \u0026 Touche LLP as independent auditor. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders. These outcomes are material to investors as they confirm the composition of the board and auditor selection.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T21:25:05.804840+00:00","company_name":"ImmunityBio, Inc.","ticker":"IBRX","filing_date":"2026-06-10"}]}